| Christann L Jackson, MD | |
|
4815 Liberty Avenue, Suite Gr59, Pittsburgh, PA 15224-2156 | |
| (412) 578-3951 | |
| (412) 578-1587 |
| Full Name | Christann L Jackson |
|---|---|
| Gender | Female |
| Speciality | Medical Genetics - Clinical Genetics (m.d.) |
| Location | 4815 Liberty Avenue, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154339810 | NPI | - | NPPES |
| 001159026 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD025329E (Pennsylvania) | Secondary |
| 207SG0201X | Medical Genetics - Clinical Genetics (m.d.) | MD025329E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christann L Jackson, MD 4815 Liberty Avenue, Suite Gr59, Pittsburgh, PA 15224-2156 Ph: (412) 578-3951 | Christann L Jackson, MD 4815 Liberty Avenue, Suite Gr59, Pittsburgh, PA 15224-2156 Ph: (412) 578-3951 |
News Archive
The U.S. Department of Defense has awarded a team of scientists and physicians from leading health care institutions across Phoenix a $1.3 million grant over three years to study traumatic brain injury and its relationship to dementia.
The Ecuadorian Ministry of Health is scaling up an innovative essential obstetric and newborn care model piloted by the USAID-funded EONC Networks Project in Cotopaxi province. The project, which is managed by the Center for Human Services, designed and implemented the model in close alliance with the MOH, USAID, and national and provincial NGOs, providers, and users.
A workplace outcome study published in The Journal of Occupational and Environmental Medicine found that offices equipped with alcohol-based hand sanitizers and hand sanitizing wipes throughout the building and at employees' desks resulted in 24.3 percent fewer healthcare claims for hand hygiene preventable illnesses - such as cold, flu and respiratory illnesses - than the office and employees in the control group without these products.
The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.
› Verified 8 days ago